Crossmark

CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome

Crossref DOI link: https://doi.org/10.1038/nbt.3853

Published Online: 2017-04-03

Published Print: 2017-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Klann, Tyler S

Black, Joshua B

Chellappan, Malathi

Safi, Alexias

Song, Lingyun

Hilton, Isaac B https://orcid.org/0000-0002-3064-8532
Crawford, Gregory E

Reddy, Timothy E https://orcid.org/0000-0002-7629-061X
Gersbach, Charles A
License Information

Text and Data Mining valid from 2017-04-03
More Information

Article History

Received: 19 September 2016

Accepted: 17 March 2017

First Online: 3 April 2017

Competing interests

: T.S.K., J.B.B., I.B.H., G.E.C., T.E.R., and C.A.G. are named inventors on patent applications related to genome engineering. T.S.K., G.E.C., T.E.R., and C.A.G. are founders of Element Genomics.